ASMB has been in the news 357% more than usual
Mar 16, 2025, 12:31 AM
-18.37%
What does ASMB do
Assembly Biosciences, a biotechnology company based in South San Francisco, develops treatments for chronic hepatitis B and other infectious diseases, with a pipeline including multiple antiviral agents. The company, which went public in December 2010, employs 65 people.
ASMB has been in the news recently: The provided information does not contain any relevant details about Assembly Biosciences or its related entities. It primarily focuses on political issues in New York and personal matters involving Bill Belichick.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.